Weibel–Palade body
Weibel–Palade bodies are the storage granules of endothelial cells, the cells that form the inner lining of the blood vessels and heart.[1] They manufacture, store and release two principal molecules, von Willebrand factor and P-selectin, and thus play a dual role in hemostasis and inflammation.[2]
Etymology
[edit]Weibel–Palade bodies were initially described by the Swiss anatomist Ewald R. Weibel and the Romanian physiologist George Emil Palade in 1964.[3] Palade won Nobel Prize in Physiology and Medicine in 1974 for his work on the function of organelles in cells.
Constituents
[edit]There are two major components stored within Weibel–Palade bodies. One is von Willebrand factor (vWF), a multimeric protein that plays a major role in blood coagulation.[4] Storage of long polymers of vWF gives this specialized lysosomal structure an oblong shape and striated appearance on electron microscope.[5] The other is P-selectin,[6][7] which plays a central role in the ability of inflamed endothelial cells to recruit passing leukocytes (white blood cells), allowing them to exit the blood vessel (extravasate) and enter the surrounding tissue, where they can migrate to the site of infection or injury.
Additional Weibel–Palade body components are the chemokines interleukin-8 and eotaxin-3, endothelin-1, angiopoietin-2, osteoprotegerin, the P-selectin cofactor CD63/lamp3,[8] and α-1,3-fucosyltransferase VI.
Production
[edit]Multimeric vWF is assembled head-to-head in the Golgi apparatus from tail-to-tail vWF dimers. vWF multimers condense and twist into long, helical, mostly parallel tubules separated by a less dense matrix of protein domains protruding from the tubules.[9] The Golgi then buds off clathrin-coated vesicles which consist almost exclusively of vWF.
Immature Weibel–Palade bodies remain near the nucleus, where they acquire more membrane proteins and then disperse throughout the cytoplasm, carried along microtubules by kinesins.[8] Clathrin-coated vesicles bud from immature Weibel–Palade bodies, reducing their volumes, condensing their contents, and removing select membrane proteins. Maturing Weibel–Palade bodies may also fuse with each other.[9]
The only parallel organelle in physiology is the alpha-granule of platelets, which also contains vWF.[10][11] Weibel–Palade bodies are the main source of vWF, while α-granules probably play a minor role.
Secretion
[edit]Weibel-Palade bodies undergo a complex maturation process following their dissociation from the trans-Golgi network (TGN) which involves recruitment of a large number of membrane proteins.[12] These include Rab GTPases such as Rab27A,[13] Rab3B[14] and Rab3D,[15] Rab effectors and SNARE proteins, which together form the exocytotic machinery of Weibel-Palade bodies.[16]
The small subset of Weibel–Palade bodies tethered at the cell periphery to the actin cortex serve as a readily releasable pool that's replenished by a larger pool of microtubule-associated bodies in the cell interior.[8]
The contents of Weibel–Palade bodies are secreted by one of three mechanisms.[9] Some undergo exocytosis individually in a rapid, sub-second fusion event,[17] while others fuse transiently to the plasma membrane in a "lingering kiss" that opens a pore large enough for only their smaller cargo (e.g. IL-8, CD63) to diffuse out.[9] In some cases this is accompanied by the formation of an actomyosin ring complex around the fusing Weibel-Palade body.[18] Weibel–Palade bodies may also coalesce into larger vesicles called secretory pods, for multigranular exocytosis.[9] Secretory pod formation is mediated by interposition of tiny nanovesicles between bodies. As Weibel–Palade bodies fuse together into secretory pods, their vWF cargo loses its tubular form for spaghetti-like strings that are then exocytosed through a fusion pore.[9] Whether cargo besides vWF is exocytosed from secretory pods or selectively retained is uncertain. Different modes of cargo release from Weibel–Palade bodies may be a mechanism for differential release of subsets of molecules in different physiological conditions.[9]
During secretion, the vWF molecules fuse together into the final concatamer "strings".[19]
Clinical significance
[edit]The importance of Weibel–Palade bodies are highlighted by some human disease mutations. Mutations within vWF are the usual cause of the most common inherited bleeding disorder, von Willebrand disease. VWD has an estimated prevalence in some human populations of up to 1%, and is most often characterized by prolonged and variable mucocutaneous bleeding. Type III von Willebrand Disease is a severe bleeding disorder, like severe hemophilia type A or B. VWF acts in primary hemostasis to recruit platelets at a site of injury, and is also important in secondary hemostasis, acting as a chaperone for coagulation factor VIII (FVIII).[20]
See also
[edit]References
[edit]- ^ Standring, S (2016). Gray's anatomy : the anatomical basis of clinical practice (Forty-first ed.). Elsevier Limited. p. 132. ISBN 9780702052309.
- ^ Valentijn KM, Eikenboom J (April 2013). "Weibel–Palade bodies: a window to von Willebrand disease". Journal of Thrombosis and Haemostasis. 11 (4): 581–92. doi:10.1111/jth.12160. PMID 23398618.
- ^ Weibel ER, Palade GE (October 1964). "New Cytoplasmic Components in Arterial Endothelia". The Journal of Cell Biology. 23 (1): 101–12. doi:10.1083/jcb.23.1.101. PMC 2106503. PMID 14228505.
- ^ Wagner DD, Olmsted JB, Marder VJ (October 1982). "Immunolocalization of von Willebrand protein in Weibel–Palade bodies of human endothelial cells". The Journal of Cell Biology. 95 (1): 355–60. doi:10.1083/jcb.95.1.355. PMC 2112360. PMID 6754744.
- ^ Tuma RF, Durán WN, Ley K, eds. (2008). Microcirculation (2nd ed.). Amsterdam: Elsevier/Academic Press. pp. 38. ISBN 978-0-12-374530-9.
- ^ Bonfanti R, Furie BC, Furie B, Wagner DD (April 1989). "PADGEM (GMP140) is a component of Weibel–Palade bodies of human endothelial cells" (PDF). Blood. 73 (5): 1109–12. doi:10.1182/blood.V73.5.1109.1109. PMID 2467701.
- ^ McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L, Bainton DF (July 1989). "GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel–Palade bodies". The Journal of Clinical Investigation. 84 (1): 92–9. doi:10.1172/JCI114175. PMC 303957. PMID 2472431.
- ^ a b c Doyle EL, Ridger V, Ferraro F, Turmaine M, Saftig P, Cutler DF (October 2011). "CD63 is an essential cofactor to leukocyte recruitment by endothelial P-selectin". Blood. 118 (15): 4265–73. doi:10.1182/blood-2010-11-321489. PMID 21803846.
- ^ a b c d e f g Valentijn KM, Sadler JE, Valentijn JA, Voorberg J, Eikenboom J (May 2011). "Functional architecture of Weibel–Palade bodies". Blood. 117 (19): 5033–43. doi:10.1182/blood-2010-09-267492. PMC 3109530. PMID 21266719.
- ^ Blair, Price; Flaumenhaft, Robert (2009-07-17). "Platelet α–granules: Basic biology and clinical correlates". Blood Reviews. 23 (4): 177–189. doi:10.1016/j.blre.2009.04.001. ISSN 0268-960X. PMC 2720568. PMID 19450911.
- ^ Kanaji, S.; Fahs, S.A.; Shi, Q.; Haberichter, S.L.; Montgomery, R.R. (August 2012). "Contribution of platelet vs. endothelial VWF to platelet adhesion and hemostasis". Journal of Thrombosis and Haemostasis. 10 (8): 1646–1652. doi:10.1111/j.1538-7836.2012.04797.x. PMC 3419786. PMID 22642380.
- ^ Schillemans, M.; Karampini, E.; Kat, M.; Bierings, R. (January 2019). "Exocytosis of Weibel–Palade bodies: how to unpack a vascular emergency kit". Journal of Thrombosis and Haemostasis. 17 (1): 6–18. doi:10.1111/jth.14322. ISSN 1538-7836. PMC 7379738. PMID 30375718.
- ^ Hannah, MJ; Hume, AN; Arribas, M; Williams, R; Hewlett, LJ; Seabra, MC; Cutler, DF (2003-10-01). "Weibel-Palade bodies recruit Rab27 by a content-driven, maturation-dependent mechanism that is independent of cell type". Journal of Cell Science. 116 (19): 3939–3948. doi:10.1242/jcs.00711. ISSN 1477-9137. PMID 12928333.
- ^ Bierings, R; Hellen, N; Kiskin, N; Knipe, L; Fonseca, AV; Patel, B; Meli, A; Rose, M; Hannah, MJ; Carter, T (2012-09-27). "The interplay between the Rab27A effectors Slp4-a and MyRIP controls hormone-evoked Weibel-Palade body exocytosis". Blood. 120 (13): 2757–2767. doi:10.1182/blood-2012-05-429936. ISSN 0006-4971. PMC 3501642. PMID 22898601.
- ^ Knop, Markus; Aareskjold, Elin; Bode, Günther; Gerke, Volker (2004-08-04). "Rab3D and annexin A2 play a role in regulated secretion of vWF, but not tPA, from endothelial cells". The EMBO Journal. 23 (15): 2982–2992. doi:10.1038/sj.emboj.7600319. ISSN 0261-4189. PMC 514934. PMID 15257287.
- ^ Hordijk, S; Carter, T; Bierings, T (May 2024). "A new look at an old body: molecular determinants of Weibel-Palade body composition and von Willebrand factor exocytosis". Journal of Thrombosis and Haemostasis. 22 (5): 1290–1303. doi:10.1016/j.jtha.2024.01.015. PMID 38307391.
- ^ Conte, IL; Cookson, E; Hellen, N; Bierings, R; Mashanov, G; Carter, T (2015-10-29). "Is there more than one way to unpack a Weibel-Palade body?". Blood. 126 (18): 2165–2167. doi:10.1182/blood-2015-08-664961. ISSN 0006-4971. PMC 4626257. PMID 26377598.
- ^ Nightingale, Thomas D.; White, Ian J.; Doyle, Emily L.; Turmaine, Mark; Harrison-Lavoie, Kimberly J.; Webb, Kathleen F.; Cramer, Louise P.; Cutler, Daniel F. (2011-08-22). "Actomyosin II contractility expels von Willebrand factor from Weibel–Palade bodies during exocytosis". Journal of Cell Biology. 194 (4): 613–629. doi:10.1083/jcb.201011119. ISSN 1540-8140. PMC 3160584. PMID 21844207.
- ^ Lenting PJ, Christophe OD, Denis CV (26 March 2015). "von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends". Blood. 125 (13): 2019–28. doi:10.1182/blood-2014-06-528406. PMID 25712991. S2CID 27785232.
- ^ Valentijn KM, Eikenboom J (April 2013). "Weibel-Palade bodies: a window to von Willebrand disease". J Thromb Haemost. 11 (4): 581–92. doi:10.1111/jth.12160. PMID 23398618.
External links
[edit]- Weibel-Palade Bodies at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
